Journals / European journal of rhinology and allergy (Online) / 2019 / Cilt: 2 - Sayı: 2

Small Lymphocytic Lymphoma Arising from the Nasopharynx

Pages
64–67
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no mass observed on endoscopic and radiologicexaminations, which were performed 24 months after treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The majority of nodal or extranodal lymphomas of the head and neck are Non-Hodgkin’s lymphomas (NHL).
📊
Key Findings & Data:Small lymphocytic lymphoma is another subtype of B-cell NHL, representing 5%-10% of all NHL.
💡
Conclusion & Impact:There was no mass observed on endoscopic and radiologicexaminations, which were performed 24 months after treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The majority of nodal or extranodal lymphomas of the head and neck are Non-Hodgkin’s lymphomas (NHL). Most ofthem are B-cell tumors. T-cell tumors and rarely natural killer cell tumors are the other subgroups. Diffuse large celllymphoma is the most frequently seen type of B-cell NHL and is followed by follicular lymphoma. Small lymphocytic lymphoma is another subtype of B-cell NHL, representing 5%-10% of all NHL. The treatment is performed withradiotherapy and/or chemotherapy, depending on the stage of the disease. In this study, we present the case of a62-year-old female diagnosed with B-cell small lymphocytic lymphoma arising from the nasopharynx. The patientdescribed as Stage 1E according to the Ann Arbor staging system was referred to the hematology/oncology clinic.Radiotherapy was selected as the treatment modality. There was no mass observed on endoscopic and radiologicexaminations, which were performed 24 months after treatment.

🔖

Cite This Article

AYDOĞDU, D., AVUNDUK, M. C., ÜLKÜ, Ç. H., MUKHTAROVA, E. (2022). Small Lymphocytic Lymphoma Arising from the Nasopharynx. European journal of rhinology and allergy (Online), Cilt: 2 - Sayı: 2, 64–67. https://ajindex.com/articles/511934

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. DePena CA, Tassel P, Lee YY. Lymphoma of the head and neck. Radiol Clin North Am. 1990;28:723-743
  2. Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P. Extranodal lymphomas of the head and neck. A 20-year experience. Arch Otolaryngol Head Neck Surg 1997; 123: 1318-23. [CrossRef] 3. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care (Engl) 2004; 13: 279-87. [CrossRef] 4. Minca EC, Popat SR, Chadha MK, Merzianu M. Small lymphocytic lymphoma obscuring microscopic tonsillar squamous cell carcinoma: an unknown occurrence with a known primary. Head Neck Pathol 2012; 6: 125-9. [CrossRef] 5. Molony NC, Stewart A, Ah-See K, McLaren M. Hodgkin’s lymphoma of the nasopharynx. J Laryngol Otol 1998; 112: 103-5. [CrossRef] 6. Hoppe RT, Burke JS, Glatstein E, Kaplan HS. Non-Hodgkin’s lymphoma. Involvement of Waldeyer’s ring. Cancer 1978; 42: 1096-104. [CrossRef] 7. Jacobs C, Hoppe RT. Non-Hodgkin’s lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phy 1985; 11: 357-64. [CrossRef] 8. Shima N, Kobashi Y, Tsutsui K, Ogawa K, Maetani S, Nakashima Y, et al. Extranodal non-Hodgkin’s lymphoma of the head and neck. A clinicopathologic study in the Kyoto-Nara area of Japan. Cancer 1990; 66: 1190-7. [CrossRef] 9. Tram Do B, Charpentier AM, Bourré-Tessier J, Maietta A, Doucet S, Ayad T, et al. Unusual presentation for small lymphocytic lymphoma: Case report of a man with bilateral ear involvement and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 136: 45-7. [CrossRef] 10. Kyasa MJ, Hazlett L, Parrish RS, Schichman SA, Zent CS. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of sewcond malignancy, which is the most common cause of death. Leuk Lymphoma 2004; 45: 507-13. [CrossRef]